DOV Pharmaceutical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Published: Nov 05, 2007
SOMERSET, NJ--(Marketwire - November 05, 2007) DOV Pharmaceutical, Inc. ("DOV," or the "Company") (OTCBB: DOVP) (PINKSHEETS: DOVP) announced today that Barbara Duncan, DOV's Chief Executive Officer, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6th at 5:05 pm EST at the Palace Hotel in New York City. Ms. Duncan will discuss the Company's clinical and preclinical development plans. Ms. Duncan's slide presentation may be accessed through a link in the investor relations section of DOV's website: www.dovpharm.com. Presentations will be archived and available after the conference for a period of 90 days.